2003•European Journal of PharmacologyRequires access

Azithromycin reverses anticancer drug resistance and modifies hepatobiliary excretion of doxorubicin in rats

Emiko Asakura, Hironao Nakayama, Masami Sugie, Ying Zhao, Masayuki Nadai, Kiyoyuki Kitaichi, A. Shimizu, Mika Miyoshi, Kenji Takagi, Kenzo Takagi, Takaaki Hasegawa

Open publisher page 38 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 38 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Doxorubicin, Multidrug resistance-associated protein 2, Azithromycin, P-glycoprotein, Pharmacology, Pharmacokinetics, Multiple drug resistance, Excretion

Back to paper search Browse research topics Original source

Azithromycin reverses anticancer drug resistance and modifies hepatobiliary excretion of doxorubicin in rats — Research Paper | ScholarLens